{"component": "definition", "props": {"groups": [{"snippet": "means a product license application, or with respect to any product license application already filed as of the Effective Date a supplemental product license application thereto, filed with the United States FDA, or the equivalent regulatory filing required to be filed with the regulatory authorities in any other jurisdiction outside the United States.", "snippet_links": [{"key": "product-license-application", "type": "definition", "offset": [8, 35]}, {"key": "with-respect-to", "type": "clause", "offset": [40, 55]}, {"key": "as-of-the-effective-date", "type": "clause", "offset": [102, 126]}, {"key": "supplemental-product", "type": "definition", "offset": [129, 149]}, {"key": "regulatory-filing", "type": "clause", "offset": [231, 248]}, {"key": "regulatory-authorities", "type": "definition", "offset": [279, 301]}, {"key": "other-jurisdiction", "type": "definition", "offset": [309, 327]}, {"key": "outside-the-united-states", "type": "clause", "offset": [328, 353]}], "samples": [{"hash": "kKy9ccBX4cw", "uri": "/contracts/kKy9ccBX4cw#pla", "label": "License Agreement (Acorda Therapeutics Inc)", "score": 21.0, "published": true}, {"hash": "h1WqYkiLGyv", "uri": "/contracts/h1WqYkiLGyv#pla", "label": "License Agreement (Acorda Therapeutics Inc)", "score": 21.0, "published": true}, {"hash": "dEH0RsCQG0I", "uri": "/contracts/dEH0RsCQG0I#pla", "label": "License Agreement (Acorda Therapeutics Inc)", "score": 21.0, "published": true}], "size": 29, "hash": "af3db1cc257e07305062d28c7150c82b", "id": 1}, {"snippet": "means, with respect to each Barrel of Crude received by Operator at the Receipt Point(s), the pipeline loss allowance specified on the applicable Rates and Fees Tariff.", "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "by-operator", "type": "clause", "offset": [53, 64]}, {"key": "pipeline-loss-allowance", "type": "definition", "offset": [94, 117]}, {"key": "fees-tariff", "type": "definition", "offset": [156, 167]}], "samples": [{"hash": "bqGl9qvqsw4", "uri": "https://www.rrc.texas.gov/media/35rfkxq5/1-14-0.pdf", "label": "www.rrc.texas.gov", "score": 19.5114097595, "published": false}, {"hash": "jTnq5ch4GPM", "uri": "https://www.rrc.texas.gov/media/i2tlttwv/7-0-0.pdf", "label": "www.rrc.texas.gov", "score": 19.5101032257, "published": false}, {"hash": "5QeS2tO1AFk", "uri": "https://www.rrc.texas.gov/media/ginn3ycc/1-13-1.pdf", "label": "www.rrc.texas.gov", "score": 19.1848125458, "published": false}], "size": 17, "hash": "53d3ce113466fc8797f8843c08bc065e", "id": 2}, {"snippet": "means Product License Application.", "snippet_links": [{"key": "product-license-application", "type": "definition", "offset": [6, 33]}], "samples": [{"hash": "1HH8xx6iGPG", "uri": "/contracts/1HH8xx6iGPG#pla", "label": "License Agreement", "score": 31.3408622742, "published": true}, {"hash": "5rG0nnieMOt", "uri": "/contracts/5rG0nnieMOt#pla", "label": "License Agreement (Horizon Pharma PLC)", "score": 28.3976726532, "published": true}, {"hash": "5yVfBj13ffP", "uri": "/contracts/5yVfBj13ffP#pla", "label": "License Agreement (Horizon Pharma PLC)", "score": 26.1553726196, "published": true}], "size": 14, "hash": "b58a94b359c9a6df4d16932cf425d5f7", "id": 3}, {"snippet": "means the Property Law Act 2007.", "snippet_links": [{"key": "property-law-act", "type": "clause", "offset": [10, 26]}], "samples": [{"hash": "aKcegTI6BUc", "uri": "/contracts/aKcegTI6BUc#pla", "label": "Security Agreement", "score": 36.3937339783, "published": true}, {"hash": "bLqWe0acXz4", "uri": "/contracts/bLqWe0acXz4#pla", "label": "Security Agreement", "score": 27.9144420624, "published": true}, {"hash": "3ZqZVfAFJvf", "uri": "/contracts/3ZqZVfAFJvf#pla", "label": "Asset Finance Agreement", "score": 24.1300487518, "published": true}], "size": 13, "hash": "555007eec7d23e6a76de19f9e28969ab", "id": 4}, {"snippet": "means the Property Law \u2587\u2587\u2587 \u2587\u2587\u2587\u2587.", "snippet_links": [{"key": "the-property", "type": "clause", "offset": [6, 18]}], "samples": [{"hash": "evZqv5bJEVg", "uri": "/contracts/evZqv5bJEVg#pla", "label": "Security Agreement", "score": 26.9397678375, "published": true}, {"hash": "c7B6ju20jAb", "uri": "/contracts/c7B6ju20jAb#pla", "label": "Security Agreement", "score": 26.9397678375, "published": true}, {"hash": "j5IHMInq8Y3", "uri": "/contracts/j5IHMInq8Y3#pla", "label": "Security Agreement", "score": 26.2840518951, "published": true}], "size": 13, "hash": "1ff4a6b4fc05137a2e7abee6b38e4b89", "id": 5}, {"snippet": "means a Product License Application or a New Drug Application filed with the FDA or equivalents in any country.", "snippet_links": [{"key": "product-license-application", "type": "definition", "offset": [8, 35]}, {"key": "new-drug-application", "type": "definition", "offset": [41, 61]}, {"key": "the-fda", "type": "clause", "offset": [73, 80]}], "samples": [{"hash": "kzgvwYfECCw", "uri": "/contracts/kzgvwYfECCw#pla", "label": "Development and Commercialization Agreement (Neurocrine Biosciences Inc)", "score": 18.0, "published": true}, {"hash": "5XJPwxClxTM", "uri": "/contracts/5XJPwxClxTM#pla", "label": "Development and Commercialization Agreement (Neurocrine Biosciences Inc)", "score": 18.0, "published": true}, {"hash": "b7DEiEZKnoR", "uri": "https://neurocrine.gcs-web.com/static-files/74138b6e-0093-4397-8f2f-692f227ce59b", "label": "neurocrine.gcs-web.com", "score": 9.965092659, "published": false}], "size": 13, "hash": "5b84768ea0e7239aaf7a0c5aa06dd2b5", "id": 6}, {"snippet": "means Port of London Authority;", "snippet_links": [{"key": "port-of", "type": "definition", "offset": [6, 13]}, {"key": "london-authority", "type": "definition", "offset": [14, 30]}], "samples": [{"hash": "e6ZZIe3hb7y", "uri": "https://pla.co.uk/sites/default/files/2024-08/General_Directions_2024-Marked.pdf", "label": "pla.co.uk", "score": 19.1962928772, "published": false}, {"hash": "2ObN5AmlxSu", "uri": "https://pla.co.uk/sites/default/files/2024-08/General_Directions_2024-Clean.pdf", "label": "pla.co.uk", "score": 19.1744747162, "published": false}, {"hash": "edUeUmYfBLV", "uri": "https://files.pca-cpa.org/pcadocs/2017-06/11.%20Russian%20Federation%20-%20Rejoinder%20-%20Exhibits/11.%20Russian%20Federation%20-%20Rejoinder%20-%20Exhibits/RU-0219.pdf", "label": "files.pca-cpa.org", "score": 17.57289505, "published": false}], "size": 10, "hash": "c9add56520aecf627261693e8ddb3a4c", "id": 7}, {"snippet": "means a collective bargaining agreement (including a pre-hire agreement) satisfying the requirements set forth herein and in Exhibit F covering contractors in the construction industry working on the construction of the Supply Chain Facility, and a bona fide building and construction trade labor organization representing craft workers on the construction of the Supply Chain Facility.", "snippet_links": [{"key": "collective-bargaining-agreement", "type": "definition", "offset": [8, 39]}, {"key": "hire-agreement", "type": "clause", "offset": [57, 71]}, {"key": "the-requirements", "type": "clause", "offset": [84, 100]}, {"key": "exhibit-f", "type": "definition", "offset": [125, 134]}, {"key": "construction-industry", "type": "definition", "offset": [163, 184]}, {"key": "construction-of-the", "type": "clause", "offset": [200, 219]}, {"key": "chain-facility", "type": "definition", "offset": [227, 241]}, {"key": "bona-fide", "type": "definition", "offset": [249, 258]}, {"key": "construction-trade", "type": "definition", "offset": [272, 290]}, {"key": "labor-organization", "type": "definition", "offset": [291, 309]}], "samples": [{"hash": "6voEQnm2MVV", "uri": "/contracts/6voEQnm2MVV#pla", "label": "Grant Disbursement Agreement", "score": 32.3720397949, "published": true}, {"hash": "4sZE1HKlXMV", "uri": "/contracts/4sZE1HKlXMV#pla", "label": "Grant Disbursement Agreement", "score": 31.4587612152, "published": true}, {"hash": "kIuGJmsZl3D", "uri": "/contracts/kIuGJmsZl3D#pla", "label": "Grant Disbursement Agreement", "score": 26.1375770569, "published": true}], "size": 7, "hash": "4edb4c16ce7f4fdd56629f112e6a3a27", "id": 8}, {"snippet": "means the Product License Approval, or its equivalent, as such term is understood by the FDA;", "snippet_links": [{"key": "product-license", "type": "definition", "offset": [10, 25]}, {"key": "the-fda", "type": "clause", "offset": [85, 92]}], "samples": [{"hash": "e82qMng58h3", "uri": "/contracts/e82qMng58h3#pla", "label": "License Agreement (Endorex Corp)", "score": 18.0, "published": true}, {"hash": "5FJkn6hTacU", "uri": "/contracts/5FJkn6hTacU#pla", "label": "License Agreement (Endorex Corp)", "score": 18.0, "published": true}, {"hash": "1TQjVB5j0Dd", "uri": "/contracts/1TQjVB5j0Dd#pla", "label": "License Agreement (Endorex Corp)", "score": 18.0, "published": true}], "size": 7, "hash": "b14e522757ab5f232729e3cf94130a28", "id": 9}, {"snippet": "means: Product License Application, a Biologics License ----- Application or a foreign equivalent of either.", "snippet_links": [{"key": "product-license-application", "type": "definition", "offset": [7, 34]}, {"key": "foreign-equivalent", "type": "definition", "offset": [79, 97]}], "samples": [{"hash": "5S7oQE28m9Y", "uri": "/contracts/5S7oQE28m9Y#pla", "label": "Option and License Agreement (Zymogenetics Inc)", "score": 18.0, "published": true}, {"hash": "3faS9il8wDO", "uri": "/contracts/3faS9il8wDO#pla", "label": "Option and License Agreement (Zymogenetics Inc)", "score": 18.0, "published": true}], "size": 7, "hash": "f59df1702a488b24c7a30854a93f5708", "id": 10}], "next_curs": "ClASSmoVc35sYXdpbnNpZGVyY29udHJhY3RzciwLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIMcGxhIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"snippet": "means a product license application, or with respect to any product license application already filed as of the Effective Date a supplemental product license application thereto, filed with the United States FDA, or the equivalent regulatory filing required to be filed with the regulatory authorities in any other jurisdiction outside the United States.", "title": "PLA", "size": 298, "id": "pla", "examples": ["For the avoidance of doubt, the reinsurance hereunder shall be effected as if there are no ceded reinsurance agreements of the Ceding Company other than the <strong>PLA</strong> Affiliate Reinsurance Agreement, the Inuring Reinsurance, this Agreement and the Retrocession Agreement."], "related": [["game", "Game", "Game"], ["network-plan", "Network plan", "Network plan"], ["toolkit", "Toolkit", "Toolkit"], ["digital-network", "Digital network", "Digital network"], ["layout-plan", "layout plan", "layout plan"]], "related_snippets": [], "updated": "2025-08-01T04:31:04+00:00"}, "json": true, "cursor": ""}}